DENTSPLY SIRONA Reports Slight Increase in Net Sales but Faces Net Loss in Q1 2026

DENTSPLY SIRONA Inc. reported a slight increase in net sales for the first quarter of 2026, reaching $880 million, compared to $879 million in the same period of 2025. However, the company experienced a net loss of $10 million, or $(0.05) per share, contrasting with a net income of $20 million, or $0.10 per share, in the prior year. The decline in profitability was attributed to increased restructuring costs of $67 million, primarily related to a new restructuring plan aimed at improving operational performance and driving shareholder value.

The company's gross profit decreased by 8.3% to $427 million, with gross profit as a percentage of net sales falling to 48.5% from 53.0% a year earlier. This decline was driven by lower sales volumes in key segments, particularly in Essential Dental Solutions and Orthodontic and Implant Solutions, as well as higher tariff costs and an unfavorable product mix. The Connected Technology Solutions segment saw a decrease in sales volumes across imaging products and CAD/CAM technologies, while Wellspect Healthcare reported a 15% increase in sales, driven by new product launches.

In terms of operational metrics, DENTSPLY SIRONA's cash provided by operating activities increased significantly to $40 million from $7 million in the previous year, primarily due to lower accounts receivable and prepaid expenses. However, cash used in investing activities rose to $53 million, reflecting higher capital expenditures and net investment hedge settlements. The company also reported a decrease in cash and cash equivalents, ending the quarter with $190 million, down from $326 million at the end of 2025.

Geographically, net sales in the Americas decreased to $330 million from $364 million, while EMEA sales increased to $435 million from $407 million, and APAC sales rose to $115 million from $108 million. The company noted that the absence of sales from Byte products, which were significant in the previous year, contributed to the overall decline in sales volumes. DENTSPLY SIRONA is currently focusing on mitigating the impacts of challenging macroeconomic conditions, including inflation and supply chain constraints, which have affected consumer confidence and spending in the dental sector.

Looking ahead, DENTSPLY SIRONA anticipates that the restructuring plan will yield approximately $120 million in annualized cost savings, which the company intends to reinvest in growth initiatives, including innovation and sales team education. The company remains committed to enhancing its product offerings and operational efficiency while navigating the complexities of the current economic landscape.